GMX Reliance Gen.

    RNS Number : 9976F
  GeneMedix PLC
  16 October 2008
   

    

    16 October 2008


    GeneMedix plc, the UK based biopharmaceutical company, announces that the name of the company has been changed with immediate effect to
"Reliance GeneMedix plc" and the company has received all the regulatory approvals in this regard.
    The company also announces that at the Annual General Meeting held on 29th August 2008 all resolutions were duly passed.


    ENQUIRIES:
 GeneMedix plc                          Tel: +353 57 932 3572
 Vinay Ranade, Chief Executive Officer

 Deloitte Corporate Finance             Tel: 020 7936 3000
 Jonathan Hinton, John Ball

 Lothbury Financial                     Tel: 020 7011 9411
 Michael Padley, Louise Davis




This information is provided by RNS
The company news service from the London Stock Exchange
 
  END 
 
CANBQLFFVBBXFBF

Grafico Azioni Reliance Genemedix (LSE:GMX)
Storico
Da Dic 2024 a Gen 2025

Grafico Azioni Reliance Genemedix (LSE:GMX)
Storico
Da Gen 2024 a Gen 2025